HK175796A - Oral dosage forms containing pimobendan - Google Patents

Oral dosage forms containing pimobendan

Info

Publication number
HK175796A
HK175796A HK175796A HK175796A HK175796A HK 175796 A HK175796 A HK 175796A HK 175796 A HK175796 A HK 175796A HK 175796 A HK175796 A HK 175796A HK 175796 A HK175796 A HK 175796A
Authority
HK
Hong Kong
Prior art keywords
dosage forms
oral dosage
forms containing
pimobendan
containing pimobendan
Prior art date
Application number
HK175796A
Other languages
English (en)
Inventor
Peter Dr Dipl-Chem Gruber
Willy Dr Dipl-Chem Roth
Schepky Dr Gottfried
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of HK175796A publication Critical patent/HK175796A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK175796A 1990-01-20 1996-09-19 Oral dosage forms containing pimobendan HK175796A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4001622A DE4001622A1 (de) 1990-01-20 1990-01-20 Orale arzneimittelformen von pimobendan

Publications (1)

Publication Number Publication Date
HK175796A true HK175796A (en) 1996-09-27

Family

ID=6398467

Family Applications (1)

Application Number Title Priority Date Filing Date
HK175796A HK175796A (en) 1990-01-20 1996-09-19 Oral dosage forms containing pimobendan

Country Status (18)

Country Link
EP (1) EP0439030B1 (da)
JP (1) JP2608183B2 (da)
KR (1) KR0163056B1 (da)
AT (1) ATE87481T1 (da)
AU (1) AU630536B2 (da)
CA (1) CA2034569C (da)
DE (2) DE4001622A1 (da)
DK (1) DK0439030T3 (da)
ES (1) ES2054379T3 (da)
FI (1) FI96274C (da)
HK (1) HK175796A (da)
HU (1) HU207948B (da)
IE (1) IE64659B1 (da)
IL (1) IL96995A (da)
NO (1) NO176305C (da)
NZ (1) NZ236834A (da)
PT (1) PT96506B (da)
ZA (1) ZA91372B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
JP3996626B2 (ja) * 2004-06-22 2007-10-24 塩野義製薬株式会社 口腔内速崩壊錠
JP4572296B2 (ja) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
JP2006028130A (ja) * 2004-07-21 2006-02-02 Toa Eiyo Ltd ピモベンダン経口投与製剤
JP4572293B2 (ja) * 2004-07-21 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
EP1937270A1 (en) * 2005-09-21 2008-07-02 Brystol-Myers Squibb Company Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
JP4572300B2 (ja) * 2006-01-19 2010-11-04 トーアエイヨー株式会社 ピモベンダン経口投与製剤
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
PE20081482A1 (es) * 2006-12-20 2008-12-23 Novartis Ag Capsulas de gelatina que contienen un acido
FR2934156B1 (fr) * 2008-07-23 2010-09-24 Virbac Medicament appetissant a administration orale sous forme solide
WO2010055119A2 (en) * 2008-11-17 2010-05-20 Novartis Ag Pharmaceutical composition comprising pimobendan
ES2436716T3 (es) 2008-11-25 2014-01-03 Boehringer Ingelheim Vetmedica Gmbh Pimobendan para uso en el tratamiento de la cardiomiopatía hipertrófica en gatos
NL1037569C2 (en) 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
US20120289517A1 (en) * 2009-12-29 2012-11-15 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
US20130035344A1 (en) * 2009-12-29 2013-02-07 Kowa Co., Ltd. Pharmaceutical composition for oral administration
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN106729723A (zh) * 2016-11-21 2017-05-31 青岛农业大学 一种含匹莫苯丹的药物组合物及其制备方法
US20240197727A1 (en) 2022-12-15 2024-06-20 Boehringer Ingelheim Vetmedica Gmbh Solid dispersions comprising amorphous pimobendan and one or more stabilizing polymers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
DE2837161A1 (de) * 1978-08-25 1980-03-06 Thomae Gmbh Dr K Neue benzimidazole und deren verwendung
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
JPS60163823A (ja) * 1984-02-03 1985-08-26 Taisho Pharmaceut Co Ltd 経口投与製剤
EP0266707B1 (en) * 1986-11-03 1992-01-22 Schering Corporation Sustained release labetalol tablet
DE3728244A1 (de) * 1987-08-25 1989-03-09 Thomae Gmbh Dr K Neue (-)-benzimidazole, deren herstellung und diese verbindungen enthaltende arzneimittel
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
DE3805635A1 (de) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
JPH01258621A (ja) * 1988-04-06 1989-10-16 Fujimoto Seiyaku Kk 吸収が調節されたジラゼプ錠
JPH023609A (ja) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk 塩酸ニカルジピンを活性成分とする持効性製剤

Also Published As

Publication number Publication date
PT96506B (pt) 1998-06-30
AU6945491A (en) 1991-07-25
NO176305B (no) 1994-12-05
KR0163056B1 (ko) 1998-12-01
HU910177D0 (en) 1991-08-28
HU207948B (en) 1993-07-28
NO910213D0 (no) 1991-01-18
EP0439030A2 (de) 1991-07-31
JPH04210919A (ja) 1992-08-03
EP0439030A3 (en) 1991-10-16
FI910263A0 (fi) 1991-01-18
EP0439030B1 (de) 1993-03-31
CA2034569C (en) 2002-03-19
ZA91372B (en) 1992-09-30
IE64659B1 (en) 1995-08-23
AU630536B2 (en) 1992-10-29
KR910014120A (ko) 1991-08-31
ES2054379T3 (es) 1994-08-01
DK0439030T3 (da) 1993-08-16
CA2034569A1 (en) 1991-07-21
NO910213L (no) 1991-07-22
HUT56494A (en) 1991-09-30
NZ236834A (en) 1995-10-26
IL96995A (en) 1994-11-11
FI96274C (fi) 1996-06-10
JP2608183B2 (ja) 1997-05-07
IE910165A1 (en) 1991-07-31
FI96274B (fi) 1996-02-29
FI910263A (fi) 1991-07-21
NO176305C (no) 1995-03-15
DE59100067D1 (de) 1993-05-06
IL96995A0 (en) 1992-03-29
DE4001622A1 (de) 1991-07-25
ATE87481T1 (de) 1993-04-15
PT96506A (pt) 1991-10-15

Similar Documents

Publication Publication Date Title
EP0439030A3 (en) Oral dosage forms containing pimobendan
GR3032723T3 (en) 10-desacetoxytaxol derivatives.
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
DE69013782D1 (de) Sauerstoffundurchlässige amorphe Polyamide.
SG65636A1 (en) Orally administrable pharmaceutical formulations
ZA927500B (en) Substituted imidazolyl-propenoic acid derivatives.
EP0455243A3 (en) Draft tube, direct contact crystallizer
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
EP0457960A3 (en) High acid concentration dialysates
HUP0101415A3 (en) 3,7-diazabicyclo [3.3.1]-nonane-carboxylic acid salts, pharmaceutical preparation containing thereof, methods for their preparation and their use
IT8583453A0 (it) Gruppo di trasferimento del pietrisco per profilatrice trasferitrice per massicciata e profilatrice cosi' equipaggiata.
IT8445702A0 (it) Dispositivo per il trasporto dei telai portapellicole in macchina sviluppatrice film.
ITPS910019A0 (it) -inserto per implantologia endossea in odontoiatria.
EP0575583A4 (en) BICYCLOPOLYAZAMACROCYCLOCARBOXYLIC ACID COMPLEXES, THEIR CONJUGATES, THEIR PREPARATION METHODS AND THEIR USES AS RADIOPHARMACEUTICAL AGENTS.
IT9021846A1 (it) Involucro pretettivo, particolarmente studiato per l'impiego in ambito ospedaliero.
FR2654928B1 (fr) Lit, en particulier lit d'hopital.
ZA928736B (en) Amino acid derivatives.
IE901205L (en) Amino acid derivatives.
IE901219L (en) Amino acid derivatives.
IE900773L (en) Amino acid derivatives.
AR243389A1 (es) Neumoperitoneo endoscopico automatico
IT223688Z2 (it) Scocca per carrozzine per bambini.
IT8720773A0 (it) Modello studio in particolare per interventi di implantologia orale.
ITMI910134A1 (it) Lettino o materassino per l'irradiazione integrale, in particolare con raggi u. v.
ES262647Y (es) "saco de dormir,perfeccionado".

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20110110